Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Veramarx

Veramarx?uq=XnI5dm0O
2012 FOUNDED
PRIVATE STATUS
1-10 EMPLOYEES
Accelerator/Inc LATEST DEAL TYPE
$20K LATEST DEAL AMOUNT
2 INVESTORS
Description

Developer of a molecular diagnostic tests designed to diagnose lyme diseases. The company's molecular diagnostic tests offers multi-analyte and algorithm based VMX-LD which measures multiple biomarkers known to occur soon after Lyme disease infections, enabling patients to diagnose early stage lyme diseases and recover it.

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Other Healthcare Services
Other Industries
Diagnostic Equipment
Primary Office
  • Post Office Box 1014
  • Dedham, MA 02027
  • United States

+1 (720) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Veramarx’s full profile, request a free trial.

Veramarx Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Accelerator/Incubator 01-Feb-2017 $20K 00000 00000 Completed Generating Revenue
3. Convertible Debt 01-Jan-2016 00000 00000 Completed Startup
2. Seed Round 01-May-2015 $400K $400K 000.00 Completed Startup
1. Capitalization 01-Jul-2013 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Veramarx Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
gener8tor Accelerator/Incubator Minority 000 0000 000000 0
SoundBoard Angel Fund Angel Group Minority 000 0000 000000 0

Veramarx Executive Team (3)

Name Title Board
Seat
Contact
Info
Whitney Richards Founder, Executive Chairman & Co-Chief Executive Officer
Mark Duncan Ph.D CSO
David Macdonald Co-Founder & Executive Board Member

Veramarx Board Members (1)

Name Representing Role Since Contact
Info
David Macdonald Veramarx Co-Founder & Executive Board Member 000 0000